We have previously shown that the overexpression of ASM sensitized glioma cells to cytostatic therapy [20] while chronic hepatitis C infection and non-alcoholic fatty liver disease is associated with an increased serologic ASM activity [21]. This evidence concerns the gene SMPD1 and central nervous system cancer.